GLP2 · 30 mg
Dual GIP/GLP-1 receptor research peptide in a 30 mg batch-coded vial, with its lot report published in full.
$89.00$139.00
Metabolic Research
GLP3 30 mg
$169.00$249.0099.6% purity · Batch RT30-260803
Triple-agonist research peptide studied for GIP, GLP-1 and glucagon receptor activity in metabolic models.
Lot analysis published for this batch. Independent Janoshik Analytical testing (Aug 2026) — purity, content and endotoxin, shown unedited further down this page.1
- Third-party HPLC & mass-spec verified
- Same-day dispatch before 2 PM ET
- Cold-packed, tamper-sealed shipping
- Batch-coded and dated at fill
Research background
Retatrutide is investigated in preclinical metabolic literature for its combined action across three incretin receptor pathways. Supplied lyophilised in a sealed, batch-coded vial with a matching third-party HPLC certificate of analysis.
Research use only. This product is supplied strictly for in-vitro laboratory research by qualified professionals. It is not a drug, food or cosmetic and must not be administered to humans or animals.
Lot analysis for this batch
- Lot
- RT30-260803
- Purity (3 vials)
- 99.92 / 99.96 / 99.97 %
- Content (3 vials)
- 34.94 / 34.27 / 34.47 mg
- Endotoxin
- <1 EU/vial
- Tested by
- Janoshik Analytical, Aug 2026
Published in full and unedited — verify it with the key printed on the report.
Specifications
- Molecular formula
- C221H342N46O68
- Molar mass
- 4731.4 g/mol
- Form
- Lyophilised white powder
- Storage
- -20 °C, protect from light
- Certificate of analysis
- View batch RT30-260803
More in Metabolic Research
Tesamorelin · 10 mg
Growth hormone-releasing factor analogue studied in metabolic and body-composition research models.
$95.00$169.00
GLP3 · 20 mg
Triple-agonist research peptide (GIP / GLP-1 / glucagon) in a 20 mg batch-coded vial.
$149.00$219.00
GLP3 30 mg
$169.00